Marina B Klein Selected Research

Coinfection

1/2022	Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the North American AIDS Cohort Collaboration on Research and Design.
1/2021	Liver Fibrosis in Human Immunodeficiency Virus (HIV)-Hepatitis C Virus (HCV) Coinfection Before and After Sustained Virologic Response: What Is the Best Noninvasive Marker for Monitoring Regression?
1/2021	Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North America.
10/2018	Injection drug use, food insecurity, and HIV-HCV co-infection: a longitudinal cohort analysis.
1/2018	Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection.
1/2018	Proteomic fingerprinting in HIV/HCV co-infection reveals serum biomarkers for the diagnosis of fibrosis staging.
1/2018	Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis.
1/2018	Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients.
1/2017	Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access.
1/2017	Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marina B Klein Research Topics

Disease

32	Coinfection 01/2022 - 07/2003
20	Infections 10/2021 - 07/2003
16	Fibrosis (Cirrhosis) 01/2021 - 04/2007
15	Hepatitis C 10/2021 - 08/2004
15	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 04/2007
13	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 07/2003
8	End Stage Liver Disease 01/2022 - 06/2012
8	HIV Infections (HIV Infection) 01/2018 - 07/2003
7	Hepatitis 01/2022 - 12/2008
7	Substance-Related Disorders (Drug Abuse) 10/2021 - 08/2014
6	Liver Diseases (Liver Disease) 03/2016 - 01/2009
3	Diabetes Mellitus 10/2021 - 03/2014
3	Chronic Renal Insufficiency 01/2019 - 01/2017
3	Hypertension (High Blood Pressure) 01/2019 - 02/2015
2	Persistent Infection 07/2020 - 01/2020
2	Myocardial Infarction 01/2019 - 01/2018
2	Non-alcoholic Fatty Liver Disease 01/2018 - 11/2016
2	Hepatitis B 01/2018 - 12/2008
2	Chronic Hepatitis B 01/2017 - 01/2016
2	Disease Progression 03/2016 - 12/2004
2	Neoplasms (Cancer) 04/2014 - 08/2004
2	Opportunistic Infections (Opportunistic Infection) 08/2004 - 07/2003
1	Cicatrix (Scar) 04/2022
1	Weight Gain 10/2021
1	Binge Drinking 01/2021
1	Mental Disorders (Mental Disorder) 01/2020
1	Chronic Disease (Chronic Diseases) 01/2019
1	Condylomata Acuminata (Genital Wart) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Uterine Cervical Dysplasia 01/2019
1	Confusion (Bewilderment) 01/2018
1	Hyperlipidemias (Hyperlipidemia) 01/2018
1	Opioid-Related Disorders (Opiate Addiction) 01/2018
1	Fatty Liver 10/2017
1	Alcoholism (Alcohol Abuse) 01/2017
1	Reinfection 01/2017
1	Cocaine-Related Disorders (Cocaine Addiction) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2015

Drug/Important Bio-Agent (IBA)

20	Pharmaceutical PreparationsIBA 12/2019 - 07/2003
15	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2009
14	Antiviral Agents (Antivirals)IBA 10/2021 - 01/2011
8	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2009
7	Biomarkers (Surrogate Marker)IBA 01/2018 - 04/2011
6	InterferonsIBA 01/2021 - 07/2008
5	Protease Inhibitors (Protease Inhibitor)IBA 11/2016 - 06/2009
4	Ribavirin (Virazole)FDA LinkGeneric 01/2021 - 07/2008
4	Aspartic Acid (Aspartate)FDA Link 03/2016 - 01/2015
3	VaccinesIBA 07/2020 - 01/2019
3	Cocaine (Cocaine HCl)IBA 01/2018 - 01/2016
3	Lipopolysaccharide ReceptorsIBA 01/2017 - 07/2014
3	SimeprevirIBA 04/2016 - 11/2014
2	abacavir (Ziagen)FDA Link 01/2018 - 08/2015
2	Interferon LambdaIBA 01/2017 - 03/2015
2	SofosbuvirIBA 04/2016 - 11/2014
2	Interleukin-6 (Interleukin 6)IBA 03/2016 - 07/2014
2	Insulin (Novolin)FDA Link 03/2016 - 09/2012
2	Reverse Transcriptase InhibitorsIBA 01/2016 - 06/2009
2	TransferasesIBA 01/2016 - 04/2007
2	Citalopram FDA LinkGeneric 07/2014 - 07/2008
2	Hyaluronic Acid (Hyaluronan)IBA 07/2014 - 01/2011
1	Darunavir (Prezista)FDA Link 01/2022
1	Atazanavir Sulfate (Reyataz)FDA Link 01/2022
1	Integrase InhibitorsIBA 10/2021
1	IntegrasesIBA 10/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Combined VaccinesIBA 01/2020
1	CholesterolIBA 01/2019
1	Keratin-18 (Keratin 18)IBA 01/2018
1	Methadone (Dolophine)FDA LinkGeneric 01/2018
1	ProteomeIBA 01/2018
1	Crack CocaineIBA 01/2017
1	C-Reactive ProteinIBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	Chemokine CCL5IBA 01/2017
1	Alanine Transaminase (SGPT)IBA 11/2016
1	ombitasvirIBA 04/2016
1	dasabuvirIBA 04/2016
1	daclatasvirIBA 04/2016
1	Ritonavir (Norvir)FDA Link 04/2016
1	paritaprevirIBA 04/2016
1	sofosbuvir drug combination ledipasvirIBA 04/2016
1	KynurenineIBA 03/2016
1	trans-crotonin (CTN)IBA 03/2016
1	Fatty Acid-Binding ProteinsIBA 03/2016
1	Proteins (Proteins, Gene)FDA Link 03/2016
1	lipopolysaccharide-binding proteinIBA 03/2016
1	RacivirIBA 01/2016
1	Tenofovir (Viread)FDA Link 01/2016
1	lamivudine drug combination abacavir FDA Link 01/2016
1	Emtricitabine (Emtriva)FDA Link 01/2016
1	CreatinineIBA 01/2016
1	Transaminases (Aminotransferases)IBA 02/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2015

Therapy/Procedure

27	Therapeutics 04/2022 - 04/2007
15	Highly Active Antiretroviral Therapy (HAART) 10/2021 - 07/2003
5	Art Therapy 01/2019 - 01/2011
1	Patient Discharge 01/2020
1	Lasers (Laser) 01/2018
1	Secondary Prevention 11/2016
1	Aftercare (After-Treatment) 05/2015